Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy
The Epilepsy Wellness Center: Incorporating Multidimensional Self-management Psychosocial Interventions in Epilepsy Care Improves the Well-being of Individuals With Epilepsy: a Feasibility and Proof-of-concept Study
1 other identifier
interventional
332
1 country
1
Brief Summary
The purpose of this study is to incorporate multidimensional self-management programs into the routine care of epilepsy patients. Consenting patients will enroll in one of four interventions that help improve medication adherence, increase seizure awareness and documentation, improve memory and deal with stress and depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2018
CompletedFirst Posted
Study publicly available on registry
March 30, 2018
CompletedStudy Start
First participant enrolled
June 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 18, 2020
CompletedDecember 20, 2024
December 1, 2024
1.7 years
March 14, 2018
December 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Quality of Life in Epilepsy-10 scores
This is a well-validated measure of quality of life for epilepsy patients. The unit of measure is a composite score ranging from 0-100 with higher scores indicating better quality of life.
To be administered at baseline (upon subject screening), pre-intervention (with 2 weeks prior to intervention), post-intervention (between 6 weeks to 3 months post-intervention), and delayed post-intervention (within 4&1/2 to 6 months post-intervention)
Study Arms (1)
Epilepsy Patients
EXPERIMENTALThe group will receive the module (a 1-2 hour course on either medication adherence, seizure documentation, memory improvement or stress management) right after a baseline assessment. A post assessment and delayed post assessment will be conducted after the module is administered.
Interventions
Some subjects will be enrolled in a medication adherence course.
Some subjects will be enrolled in a seizure documentation course.
Some subjects will be enrolled in a memory improvement course.
Some subjects will be enrolled in a stress management course.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of epilepsy using established criteria
- Patient self-identified as own primary caregiver
- English fluency
- Ability to provide informed consent
- Ability to complete the study assessments
You may not qualify if:
- History of non-epileptic seizures
- History of cognitive impairments that prevents them from providing informed consent and completing study assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- Dupont Fund, Jesse Ballcollaborator
- Florida Blue Foundationcollaborator
- Riverside Hospital Foundationcollaborator
Study Sites (1)
UF Health Jacksonville
Jacksonville, Florida, 32209, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ramon Edmundo D Bautista, MD
University of Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2018
First Posted
March 30, 2018
Study Start
June 6, 2018
Primary Completion
February 18, 2020
Study Completion
February 18, 2020
Last Updated
December 20, 2024
Record last verified: 2024-12